The American depository shares of Australian company Mesoblast Limited (MESO) have returned a mere 2% year-to-date, lagging behind the iShares Nasdaq Biotechnology ETF (IBB) Index's gain of nearly 10%.
from RTT - Biotech https://ift.tt/2BF80Tn
via IFTTT
No comments:
Post a Comment